1124151

Celgene Corporation — FEI 3004991673

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 3, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Summit, NJ (United States)

Additional Details

Sponsor, Contract Research Organization